Festival of Biologics 2025
Discover our cutting-edge new platform that accelerates biologics drug development like never before: Path to IND for biologics
April 23 – 24, 2025 | San Diego, CA | Booth #733
About the Festival of Biologics 2025
Festival of Biologics 2025 will take place from April 23–24 at the San Diego Convention Center. The conference brings together biotech and pharma experts, academics, research institutes, regulators, patient groups, and payers, along with their partners across the value chain.
Festival of Biologics 2025 will cover the entire biologics drug development journey, from discovery to commercialization. Even better, the event is now certified by Continuing Professional Development (CPD) Services, so participants will receive a CPD certificate after attending.
Event details
Date: April 23-24, 2025
Format: In-person
Location: San Diego, CA
Booth number: #733
Event website: Registration form
Why Thermo Fisher Scientific?
As a leading CDMO and CRO in drug development, Thermo Fisher Scientific provides a full suite of services and solutions for biologics,or large molecule drugs. At Festival of Biologics 2025, we’re proud to introduce Path to IND for biologics—a new cutting-edge program designed by our in-house experts to address key challenges in biologics development.
With cell line development titer levels of up to 8 g/L*, state-of-the-art equipment, advanced software, and our extensive resources—including raw materials and clinical trial services—we do more than support your biologic’s development. We get you ready for Phase I clinical trials, funding and all, in just nine months.* Visit booth #733 to learn more.
Attend our expert-led session:
Path to IND for biologics: From DNA to clinical trials in just 9 months
Date: Wednesday, April 23, 2025
Time: 1 p.m. PT
Location: San Diego, CA
Join Thermo Fisher Scientific’s team of experts to explore our novel, groundbreaking approach to biologics development and scale-up. Our Path to IND for biologics transforms the journey from DNA through development to IND/IMPD submission and the initiation of Phase I clinical trials in just nine months.
We’re excited to have our biologics expert, Dr. Elena Gontarz, onsite to share this innovative approach and answer your questions. Come learn how our solutions can streamline your path from developing complex molecules, like Fc-fusion and bispecifics, to clinical trials and market commercialization.
- Discover how to cut biologics development timelines from years to months
- Get insights into the future of biologics from thought leaders in biopharma
- Network with Thermo Fisher Scientific’s team of drug development experts
Meet with our industry-leading expert
The mastermind behind our new Path to IND for biologics program, will be available for 1:1 meetings throughout the Festival of Biologics 2025. Schedule time with her to talk about our game-changing approach to biologics development.
We’ll see you at booth #733 in San Diego
We look forward to connecting with you at the Festival of Biologics 2025—your key to unlocking faster biologics development.
Visit us at booth #733 to explore our end-to-end CDMO and CRO services and solutions, as well as meet our team of biologics experts.
*Terms and conditions: Titer levels provided are estimates based on third-party results and may vary depending on molecule type or other factors. The timeline from DNA to drug product and the start of clinical trials for all Path to IND for Biologics options may vary depending on molecule type or other factors and will be finalized after third-party cell line development dates are available and confirmed. Additional charges will be incurred for this expedited timeline.
Continuing education for the pharma industry
Follow us on social for event updates
We look forward to seeing you soon